Azulfidine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Sulfasalazine.
| Product ID | 0013-0101_14feec56-0272-44f5-9315-6a496e19d251 |
| NDC | 0013-0101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Azulfidine |
| Generic Name | Sulfasalazine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1950-06-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA007073 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | SULFASALAZINE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1950-06-20 |
| Marketing End Date | 2024-08-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA007073 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1950-06-20 |
| Marketing Category | NDA |
| Application Number | NDA007073 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1950-06-20 |
| Marketing Category | NDA |
| Application Number | NDA007073 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1950-06-20 |
| Marketing End Date | 2014-03-05 |
| Marketing Category | NDA |
| Application Number | NDA007073 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-02-27 |
| Marketing Category | NDA |
| Application Number | NDA007073 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-02-27 |
| Ingredient | Strength |
|---|---|
| SULFASALAZINE | 500 mg/1 |
| SPL SET ID: | ddbe69f3-bd55-45f3-a64f-f60226c744c4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0013-0101 | Azulfidine | Sulfasalazine |
| 0013-0102 | Azulfidine | Sulfasalazine |
| 0093-3234 | Sulfasalazine | Sulfasalazine |
| 0591-0796 | Sulfasalazine | Sulfasalazine |
| 0603-5801 | Sulfasalazine | sulfasalazine |
| 10544-288 | Sulfasalazine | sulfasalazine |
| 23155-019 | Sulfasalazine | Sulfasalazine |
| 33261-756 | Sulfasalazine | sulfasalazine |
| 43353-495 | Sulfasalazine | Sulfasalazine |
| 50090-0086 | Sulfasalazine | Sulfasalazine |
| 50090-2013 | Sulfasalazine | Sulfasalazine |
| 50268-730 | Sulfasalazine | Sulfasalazine |
| 59762-0104 | Sulfasalazine | Sulfasalazine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AZULFIDINE 72071688 0689772 Live/Registered |
PHARMACIA LABORATORIES, INC. 1959-04-16 |